Konrad Jan Karczewski, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Genome, Human | 21 | 2022 | 4493 | 1.220 |
Why?
|
Genetic Variation | 19 | 2022 | 6666 | 1.150 |
Why?
|
Genomics | 8 | 2017 | 5300 | 0.930 |
Why?
|
Genes, Essential | 2 | 2020 | 182 | 0.900 |
Why?
|
Computational Biology | 7 | 2016 | 3568 | 0.820 |
Why?
|
Blood Platelet Disorders | 1 | 2020 | 58 | 0.790 |
Why?
|
Databases, Genetic | 8 | 2020 | 1807 | 0.680 |
Why?
|
Genome-Wide Association Study | 20 | 2023 | 11738 | 0.610 |
Why?
|
Pharmacogenetics | 4 | 2014 | 697 | 0.540 |
Why?
|
Molecular Sequence Annotation | 5 | 2020 | 552 | 0.520 |
Why?
|
User-Computer Interface | 3 | 2016 | 1433 | 0.470 |
Why?
|
Genetics, Population | 6 | 2020 | 1003 | 0.450 |
Why?
|
Haploinsufficiency | 3 | 2022 | 312 | 0.400 |
Why?
|
Metabolomics | 2 | 2018 | 1357 | 0.390 |
Why?
|
5' Untranslated Regions | 2 | 2021 | 259 | 0.370 |
Why?
|
Transcription Factors | 5 | 2021 | 12005 | 0.370 |
Why?
|
Disease | 3 | 2020 | 694 | 0.370 |
Why?
|
Systems Biology | 1 | 2013 | 490 | 0.360 |
Why?
|
Gene Expression Regulation | 6 | 2017 | 12447 | 0.350 |
Why?
|
Polymorphism, Single Nucleotide | 22 | 2023 | 15485 | 0.350 |
Why?
|
Software | 4 | 2021 | 4345 | 0.330 |
Why?
|
Genetic Diseases, Inborn | 1 | 2013 | 598 | 0.330 |
Why?
|
NF-kappa B | 2 | 2013 | 2563 | 0.320 |
Why?
|
Consanguinity | 3 | 2020 | 465 | 0.310 |
Why?
|
Gene Frequency | 8 | 2022 | 3701 | 0.300 |
Why?
|
Proteomics | 2 | 2018 | 3244 | 0.290 |
Why?
|
DNA Copy Number Variations | 5 | 2022 | 1894 | 0.270 |
Why?
|
Biological Specimen Banks | 3 | 2023 | 636 | 0.240 |
Why?
|
Genetic Predisposition to Disease | 13 | 2023 | 17218 | 0.240 |
Why?
|
Phenotype | 13 | 2023 | 16306 | 0.240 |
Why?
|
Genotype | 10 | 2023 | 12863 | 0.230 |
Why?
|
Sequence Analysis, DNA | 6 | 2017 | 4926 | 0.220 |
Why?
|
Haplotypes | 6 | 2021 | 2874 | 0.220 |
Why?
|
Otosclerosis | 1 | 2023 | 113 | 0.220 |
Why?
|
Open Reading Frames | 4 | 2020 | 840 | 0.210 |
Why?
|
Homozygote | 4 | 2023 | 1849 | 0.210 |
Why?
|
DNA Mutational Analysis | 5 | 2020 | 4317 | 0.200 |
Why?
|
Quantitative Trait Loci | 4 | 2017 | 1976 | 0.200 |
Why?
|
RNA Splice Sites | 2 | 2018 | 188 | 0.200 |
Why?
|
Nucleotides | 2 | 2022 | 440 | 0.190 |
Why?
|
Organelles | 1 | 2021 | 294 | 0.180 |
Why?
|
Rare Diseases | 3 | 2020 | 509 | 0.180 |
Why?
|
Proteins | 4 | 2020 | 6151 | 0.180 |
Why?
|
Models, Genetic | 3 | 2021 | 3539 | 0.180 |
Why?
|
Humans | 63 | 2022 | 708843 | 0.170 |
Why?
|
Quantitative Trait, Heritable | 1 | 2021 | 555 | 0.170 |
Why?
|
Penetrance | 2 | 2017 | 359 | 0.170 |
Why?
|
Genetics, Medical | 1 | 2020 | 319 | 0.160 |
Why?
|
Mutation | 10 | 2022 | 29262 | 0.150 |
Why?
|
Jews | 1 | 2018 | 365 | 0.150 |
Why?
|
RNA Splicing | 2 | 2018 | 877 | 0.150 |
Why?
|
Developmental Disabilities | 2 | 2021 | 1370 | 0.140 |
Why?
|
X Chromosome Inactivation | 1 | 2017 | 231 | 0.140 |
Why?
|
Alternative Splicing | 2 | 2018 | 1123 | 0.140 |
Why?
|
Warfarin | 2 | 2014 | 1440 | 0.140 |
Why?
|
Prion Diseases | 1 | 2016 | 80 | 0.140 |
Why?
|
African Americans | 4 | 2021 | 5118 | 0.140 |
Why?
|
Nervous System Malformations | 1 | 2015 | 222 | 0.130 |
Why?
|
Saccharomyces | 1 | 2013 | 65 | 0.120 |
Why?
|
Health | 1 | 2016 | 395 | 0.120 |
Why?
|
Genes | 1 | 2017 | 1977 | 0.120 |
Why?
|
Sequence Analysis, RNA | 3 | 2017 | 2040 | 0.120 |
Why?
|
Vesicular Transport Proteins | 1 | 2015 | 383 | 0.110 |
Why?
|
Exosomes | 1 | 2017 | 400 | 0.110 |
Why?
|
Genome, Fungal | 1 | 2013 | 212 | 0.110 |
Why?
|
Organ Specificity | 1 | 2017 | 2064 | 0.110 |
Why?
|
INDEL Mutation | 1 | 2013 | 269 | 0.110 |
Why?
|
Alleles | 5 | 2018 | 7090 | 0.110 |
Why?
|
Genes, Synthetic | 1 | 2011 | 90 | 0.110 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2016 | 677 | 0.110 |
Why?
|
Gene Expression Profiling | 5 | 2015 | 9556 | 0.110 |
Why?
|
Diastole | 1 | 2014 | 836 | 0.110 |
Why?
|
Systole | 1 | 2014 | 993 | 0.110 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2011 | 916 | 0.110 |
Why?
|
Genetic Association Studies | 2 | 2020 | 2709 | 0.100 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2017 | 3708 | 0.100 |
Why?
|
Regulatory Sequences, Nucleic Acid | 2 | 2012 | 778 | 0.100 |
Why?
|
Myelodysplastic Syndromes | 1 | 2020 | 1255 | 0.100 |
Why?
|
RNA, Messenger | 4 | 2020 | 13314 | 0.100 |
Why?
|
Protein Binding | 3 | 2013 | 9639 | 0.100 |
Why?
|
Human Genome Project | 1 | 2011 | 192 | 0.100 |
Why?
|
RNA, Untranslated | 1 | 2014 | 447 | 0.100 |
Why?
|
Genetic Techniques | 1 | 2013 | 440 | 0.100 |
Why?
|
Search Engine | 1 | 2012 | 136 | 0.100 |
Why?
|
Lipoproteins, HDL | 1 | 2015 | 649 | 0.100 |
Why?
|
Genome | 1 | 2019 | 1747 | 0.100 |
Why?
|
Waist Circumference | 1 | 2013 | 895 | 0.100 |
Why?
|
Guidelines as Topic | 1 | 2017 | 1418 | 0.100 |
Why?
|
Triglycerides | 2 | 2017 | 2564 | 0.090 |
Why?
|
Cooperative Behavior | 1 | 2017 | 1551 | 0.090 |
Why?
|
Exons | 3 | 2020 | 2472 | 0.090 |
Why?
|
Neurogenesis | 1 | 2015 | 833 | 0.090 |
Why?
|
Transcription Factor RelA | 1 | 2010 | 291 | 0.090 |
Why?
|
Gene Deletion | 1 | 2017 | 2838 | 0.090 |
Why?
|
Thrombophilia | 1 | 2011 | 318 | 0.090 |
Why?
|
Metabolic Networks and Pathways | 1 | 2013 | 815 | 0.090 |
Why?
|
Information Dissemination | 1 | 2017 | 1089 | 0.090 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 2878 | 0.080 |
Why?
|
Transcription, Genetic | 2 | 2020 | 7965 | 0.080 |
Why?
|
Reproducibility of Results | 3 | 2020 | 19423 | 0.080 |
Why?
|
Folic Acid | 1 | 2014 | 1228 | 0.080 |
Why?
|
Heterozygote | 3 | 2020 | 2780 | 0.080 |
Why?
|
Cohort Studies | 6 | 2021 | 39292 | 0.080 |
Why?
|
Mutation, Missense | 1 | 2016 | 2503 | 0.080 |
Why?
|
Cholesterol, HDL | 1 | 2014 | 1817 | 0.080 |
Why?
|
Evolution, Molecular | 2 | 2013 | 1959 | 0.080 |
Why?
|
Single-Cell Analysis | 1 | 2017 | 2159 | 0.080 |
Why?
|
RNA Polymerase II | 1 | 2010 | 538 | 0.070 |
Why?
|
Pakistan | 2 | 2017 | 289 | 0.070 |
Why?
|
Schizophrenia | 2 | 2022 | 6663 | 0.070 |
Why?
|
Crohn Disease | 1 | 2018 | 2277 | 0.070 |
Why?
|
Cell Cycle | 1 | 2014 | 3014 | 0.070 |
Why?
|
Genetic Testing | 2 | 2020 | 3303 | 0.070 |
Why?
|
Sample Size | 2 | 2020 | 821 | 0.070 |
Why?
|
Binding Sites | 2 | 2011 | 6276 | 0.070 |
Why?
|
Biological Evolution | 1 | 2011 | 1084 | 0.070 |
Why?
|
Pedigree | 3 | 2021 | 4724 | 0.070 |
Why?
|
United States Food and Drug Administration | 1 | 2013 | 1740 | 0.070 |
Why?
|
Drug Discovery | 1 | 2012 | 1066 | 0.060 |
Why?
|
Geography | 2 | 2018 | 681 | 0.060 |
Why?
|
Learning | 1 | 2013 | 1596 | 0.060 |
Why?
|
CpG Islands | 2 | 2020 | 1177 | 0.060 |
Why?
|
Gene Dosage | 2 | 2022 | 1271 | 0.060 |
Why?
|
Homeostasis | 1 | 2014 | 3334 | 0.060 |
Why?
|
Reference Standards | 2 | 2020 | 992 | 0.060 |
Why?
|
Aging | 1 | 2021 | 8358 | 0.060 |
Why?
|
Toll-Like Receptor 7 | 1 | 2022 | 179 | 0.050 |
Why?
|
Algorithms | 4 | 2018 | 13647 | 0.050 |
Why?
|
Signal Recognition Particle | 1 | 2020 | 43 | 0.050 |
Why?
|
MicroRNAs | 1 | 2017 | 3655 | 0.050 |
Why?
|
Models, Theoretical | 1 | 2013 | 3558 | 0.050 |
Why?
|
Curriculum | 1 | 2013 | 3329 | 0.050 |
Why?
|
Female | 15 | 2023 | 375205 | 0.050 |
Why?
|
RNA Helicases | 1 | 2020 | 135 | 0.050 |
Why?
|
Male | 14 | 2020 | 349524 | 0.050 |
Why?
|
Heart Defects, Congenital | 1 | 2015 | 4297 | 0.050 |
Why?
|
Oxidative Phosphorylation | 1 | 2021 | 489 | 0.050 |
Why?
|
Lymphocytes | 2 | 2020 | 2729 | 0.050 |
Why?
|
Biology | 1 | 2020 | 194 | 0.050 |
Why?
|
Anticoagulants | 1 | 2014 | 4293 | 0.050 |
Why?
|
Poisson Distribution | 1 | 2020 | 504 | 0.040 |
Why?
|
Base Sequence | 3 | 2020 | 13352 | 0.040 |
Why?
|
Gene Flow | 1 | 2018 | 94 | 0.040 |
Why?
|
Neuregulins | 1 | 2017 | 26 | 0.040 |
Why?
|
Blood Pressure | 1 | 2014 | 8528 | 0.040 |
Why?
|
Population Density | 1 | 2018 | 189 | 0.040 |
Why?
|
Collagen Type VI | 1 | 2017 | 26 | 0.040 |
Why?
|
Automation | 1 | 2020 | 589 | 0.040 |
Why?
|
Genes, X-Linked | 1 | 2017 | 133 | 0.040 |
Why?
|
Cell Line | 3 | 2020 | 16657 | 0.040 |
Why?
|
Finland | 1 | 2018 | 584 | 0.040 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2021 | 573 | 0.040 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2017 | 128 | 0.040 |
Why?
|
DNA, Mitochondrial | 1 | 2021 | 790 | 0.040 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2022 | 920 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2020 | 2981 | 0.040 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2017 | 308 | 0.040 |
Why?
|
Molecular Epidemiology | 1 | 2018 | 477 | 0.040 |
Why?
|
Chromosomes, Human, X | 1 | 2017 | 310 | 0.040 |
Why?
|
Brain | 2 | 2020 | 24969 | 0.040 |
Why?
|
Genes, Lethal | 1 | 2016 | 255 | 0.040 |
Why?
|
Postprandial Period | 1 | 2017 | 303 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2022 | 21194 | 0.040 |
Why?
|
Apolipoprotein C-III | 1 | 2017 | 226 | 0.040 |
Why?
|
Receptors, KIR | 1 | 2015 | 121 | 0.030 |
Why?
|
Selection, Genetic | 1 | 2020 | 882 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2020 | 1728 | 0.030 |
Why?
|
Genetic Loci | 2 | 2016 | 2587 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 14075 | 0.030 |
Why?
|
Parturition | 1 | 2018 | 391 | 0.030 |
Why?
|
Prions | 1 | 2016 | 166 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2014 | 6213 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2020 | 1421 | 0.030 |
Why?
|
Adult | 5 | 2020 | 211041 | 0.030 |
Why?
|
Interleukin-8 | 1 | 2017 | 695 | 0.030 |
Why?
|
Muscular Diseases | 1 | 2017 | 555 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2016 | 819 | 0.030 |
Why?
|
Longevity | 1 | 2020 | 1019 | 0.030 |
Why?
|
Waist-Hip Ratio | 1 | 2013 | 514 | 0.030 |
Why?
|
Embryonic Stem Cells | 1 | 2020 | 1386 | 0.030 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2013 | 259 | 0.030 |
Why?
|
Neurodegenerative Diseases | 1 | 2020 | 934 | 0.030 |
Why?
|
Mixed Function Oxygenases | 1 | 2013 | 311 | 0.030 |
Why?
|
Cholesterol | 1 | 2021 | 2866 | 0.030 |
Why?
|
Base Composition | 1 | 2011 | 306 | 0.030 |
Why?
|
Artifacts | 1 | 2020 | 1904 | 0.030 |
Why?
|
Fertility | 1 | 2016 | 712 | 0.030 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2012 | 157 | 0.030 |
Why?
|
Myocytes, Cardiac | 1 | 2020 | 1641 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2012 | 513 | 0.030 |
Why?
|
Homeodomain Proteins | 1 | 2021 | 2459 | 0.030 |
Why?
|
Quality Control | 1 | 2014 | 872 | 0.030 |
Why?
|
Fasting | 1 | 2017 | 1608 | 0.030 |
Why?
|
Rhinovirus | 1 | 2012 | 167 | 0.030 |
Why?
|
tau Proteins | 1 | 2020 | 1623 | 0.030 |
Why?
|
Congenital Abnormalities | 1 | 2015 | 696 | 0.030 |
Why?
|
Mutagenesis, Insertional | 1 | 2013 | 667 | 0.020 |
Why?
|
Behavior | 1 | 2013 | 558 | 0.020 |
Why?
|
Pan troglodytes | 1 | 2010 | 234 | 0.020 |
Why?
|
DNA, Intergenic | 1 | 2010 | 110 | 0.020 |
Why?
|
Transcription Initiation Site | 1 | 2010 | 194 | 0.020 |
Why?
|
HLA Antigens | 1 | 2015 | 1549 | 0.020 |
Why?
|
Lipids | 1 | 2021 | 3246 | 0.020 |
Why?
|
Autistic Disorder | 1 | 2017 | 1044 | 0.020 |
Why?
|
Fungal Proteins | 1 | 2013 | 933 | 0.020 |
Why?
|
Neoplasms | 2 | 2017 | 20172 | 0.020 |
Why?
|
Dietary Fats | 1 | 2017 | 2042 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2020 | 3507 | 0.020 |
Why?
|
Mendelian Randomization Analysis | 1 | 2014 | 874 | 0.020 |
Why?
|
Gene Silencing | 1 | 2015 | 1626 | 0.020 |
Why?
|
Middle Aged | 6 | 2020 | 213752 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2013 | 2062 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2020 | 4677 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2017 | 2550 | 0.020 |
Why?
|
Europe | 1 | 2014 | 3104 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2017 | 3645 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2011 | 1548 | 0.020 |
Why?
|
Parkinson Disease | 1 | 2020 | 2578 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2011 | 2281 | 0.020 |
Why?
|
Proteome | 1 | 2016 | 1767 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2015 | 1920 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2016 | 1662 | 0.020 |
Why?
|
Child | 3 | 2021 | 73636 | 0.020 |
Why?
|
Linear Models | 1 | 2016 | 5986 | 0.020 |
Why?
|
United States | 1 | 2013 | 67165 | 0.020 |
Why?
|
Cardiomyopathies | 1 | 2017 | 1819 | 0.020 |
Why?
|
Animals | 4 | 2023 | 170486 | 0.020 |
Why?
|
Mothers | 1 | 2016 | 1991 | 0.020 |
Why?
|
Species Specificity | 1 | 2010 | 2619 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2017 | 5908 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2015 | 3075 | 0.020 |
Why?
|
Adiposity | 1 | 2013 | 1734 | 0.020 |
Why?
|
Family | 1 | 2014 | 3087 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2015 | 4658 | 0.010 |
Why?
|
Coronary Disease | 1 | 2017 | 6127 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 14712 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2013 | 3156 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2020 | 58184 | 0.010 |
Why?
|
Risk Assessment | 2 | 2014 | 23284 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2013 | 11239 | 0.010 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2012 | 2100 | 0.010 |
Why?
|
Internet | 1 | 2012 | 3074 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2013 | 3934 | 0.010 |
Why?
|
Risk Factors | 2 | 2016 | 69553 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2012 | 5982 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2017 | 11323 | 0.010 |
Why?
|
Body Mass Index | 1 | 2013 | 12366 | 0.010 |
Why?
|
Time Factors | 1 | 2018 | 41038 | 0.010 |
Why?
|
Mice | 1 | 2023 | 80876 | 0.010 |
Why?
|
Prognosis | 1 | 2015 | 28919 | 0.010 |
Why?
|
Aged | 2 | 2020 | 161488 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2012 | 9774 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2012 | 10857 | 0.010 |
Why?
|
Young Adult | 1 | 2013 | 55940 | 0.000 |
Why?
|